Walther Cancer Foundation Inc.

Walther Cancer Foundation operates as a relationship-driven, invitation-only private foundation with no open grant competitions for its major institutional funding programs. The giving philosophy centers on long-term strategic partnerships with major research universities — primarily Indiana University and Purdue University — rather than broad competitive grant-making. Having invested more than $200 million since its 1985 founding (over $100 million flowing to Indiana University alone), Walther functions more as an institutional investment partner than a traditional funder, building durable research infrastructure through endowed chairs, multi-year program centers, and career development pipelines.

The foundation pursues two explicit missions that govern every funding decision: accelerating cancer discovery science (basic research, informatics, bioinformatics, translational programs) and building robust supportive oncology infrastructure (palliative care, symptom management, patient and family support). A third strategic priority — pediatric cancer research — emerged formally in August 2023 with the $10M challenge gift to Riley Children's Foundation. Any researcher or institution seeking alignment must ground their work in at least one of these three pillars.

For most applicants, the practical pathway to Walther funding is the Career Development Award in Palliative and Supportive Care in Oncology, administered through the American Society of Clinical Oncology (ASCO). This is the only openly competitive program the foundation funds, welcoming early-career clinical investigators from U.S. and international institutions who hold initial faculty appointments and are building independent research programs. Applications go through ASCO's portal, not Walther directly.

For researchers at Indiana institutions, the pathway to larger institutional grants runs through existing grantee departments at IU School of Medicine and Purdue's Institute for Cancer Research. V.P. of Programs D. Craig Brater (compensated $108,000/year) is the foundation's primary program officer and is deeply embedded in IU's institutional planning. Researchers should network actively within the IU Melvin and Bren Simon Comprehensive Cancer Center and Purdue cancer research programs to be surfaced when Walther initiates new funding rounds.

First-time applicants should understand that Walther does not publish RFPs or grant cycles for major institutional awards. The relationship typically begins when foundation staff identify a promising program gap, initiate dialogue with institutional leadership, and develop a multi-year proposal collaboratively — a process that can span 12 to 24 months before formal commitment. Cold outreach to the foundation rarely produces results.

Walther's annual total giving has been remarkably stable across more than a decade: $8.56M (FY2016), $8.80M (FY2019), $8.78M (FY2020), $9.57M (FY2021), $9.56M (FY2022), and $9.45M (FY2023 and FY2024). This sub-$1M variance across ten years signals a deliberate, sustainable payout strategy — approximately 5.7% of the foundation's $167.2M asset base in FY2024, exceeding the 5% private foundation minimum. Grants paid figures (net of multi-year commitment recognition) track slightly lower: $6.86M (FY2020), $7.03M (FY2019), $7.10M (FY2021), $7.49M (FY2023), $7.53M (FY2022).

Grant-making operates on two distinct size tiers. Major multi-year institutional commitments dominate the portfolio: $14M for the Walther Supportive Oncology Program at IU School of Medicine (2018, established five endowed chairs); $11M for the Cancer Bioinformatics Program co-managed by IU and Purdue (2020); $15M for the IU Simon Cancer Center Director's Discretionary Fund (2021–2029, approximately $1.9M/year); $10M challenge gift to Riley Children's Foundation for pediatric cancer research (announced August 4, 2023); and $5M for the Purdue Institute for Cancer Research directorship (2024). These headline commitments represent the foundation's strategic bets on building permanent research infrastructure.

Career development grants through ASCO represent a more accessible tier. The 2024 cohort committed $2.8M across 12 multi-year awards, averaging approximately $233K per awardee. Historically, individual CDA awards have ranged from approximately $60,000 to $250,000+, with two to three awards made annually. The Palliative and Supportive Oncology Award (recognition, not a research grant per se) is made annually through ASCO.

Geographic concentration is near-total: all database grantees are Indiana-based, with $21.5M recorded across three grant records entirely in Indiana. The foundation describes its reach as Indiana, Ohio, and Michigan, but direct evidence of consistent funding outside Indiana is limited. Program allocation skews approximately 60–65% toward cancer discovery and research infrastructure and 35–40% toward supportive oncology and palliative care. The foundation is financially self-sustaining from its endowment, receiving only $6,178 in external contributions in FY2024 — net investment income drives revenue at $3.43M (FY2023–2024) and $8.34M in strong markets (FY2021).

Walther Cancer Foundation occupies a distinctive niche among mid-size health research foundations: highly concentrated geographically (Indiana-first), narrowly mission-focused (cancer research and supportive oncology), and closed to unsolicited applications for institutional grants.

Walther is distinctive in two ways among these peers. First, its geographic concentration — virtually all institutional grants go to Indiana — makes it the most accessible funder in this cohort for IU and Purdue researchers, but effectively closed to others. Second, its ASCO-administered Career Development Award is a rare openly competitive program among invitation-only foundations of this size, giving palliative care researchers nationwide a viable entry point that peers like Glenn and Regenstrief do not offer. The Regenstrief Foundation (also Indianapolis-based) is a natural complement: it has directly co-funded Walther's cancer bioinformatics initiatives and shares an endowed chair, making the two foundations effectively collaborative partners for Indiana health research institutions. The Hillblom Foundation offers a secondary channel for cancer biology researchers in California who cannot access Walther's invitation track.

The most visible 2026 activity centers on dual ASCO award announcements: Dr. Frank D. Ferris and Dr. Charles L. Loprinzi both received the 2026 Walther Cancer Foundation Palliative and Endowed Supportive Oncology Award at ASCO's Palliative and Supportive Care in Oncology Symposium — a notable expansion from prior years when a single recipient was named annually.

In 2025, the ASCO Career Development Award program continued its annual cycle with two new recipients: Dr. Rahela Aziz-Bose and Dr. Rachel Rodenbach each received Career Development Awards in Palliative and Supportive Care in Oncology. Dr. Karen Mustian received the 2025 Palliative and Endowed Supportive Oncology Award.

The headline 2024 institutional activity was the appointment of Dr. Jiang Bian as inaugural holder of the Walther and Regenstrief Endowed Chair in Cancer Informatics at Indiana University — a joint endowment reflecting the deepening Walther-Regenstrief partnership in data science. Walther also committed $5M to Purdue's Institute for Cancer Research directorship in 2024 and committed $2.8M to ASCO for a 12-award Career Development cohort.

The $10M challenge gift to Riley Children's Foundation (announced August 4, 2023) remains the most significant recent strategic expansion. By creating a 1:1 match for donor-established endowed children's cancer research funds, the gift could generate $20M+ total for pediatric oncology research at IU School of Medicine. President Thomas Grein's explicit framing — "we have the opportunity to give children decades more life" — signals that pediatric cancer research has joined discovery science and supportive oncology as a formal third pillar of Walther's giving strategy.

The single most important fact about Walther is that it does not accept unsolicited proposals for institutional grants. The foundation's database record confirms `preselected_only: true` and `application_instructions: '__none__'`. Preparing a polished grant proposal and emailing it cold will not work. The following tips are calibrated to Walther's actual award pathways.

For ASCO Career Development Award applicants (the only open competition): - This pathway is open to early-career clinical investigators — typically within three to five years of their initial faculty appointment — working in palliative and supportive care oncology. International applicants are eligible, which is rare for Walther-administered programs. - Applications are submitted through ASCO's grant management portal (asco.org), not walther.org. A documented deadline is September 24 (2020 cycle); expect similar fall deadlines. Monitor ASCO.org and CAPC.org starting each June for the current cycle's call for applications. - Emphasize clinical translation: the award targets investigators bridging research and direct patient care, not basic scientists. Frame your proposal around measurable patient outcomes in symptom management, palliative care delivery, or family support. - Use the language from Walther's mission statement: "comprehensive approach for supporting patients with cancer and their families." The phrase "interdisciplinary and inter-institutional" research is also explicitly valued.

For Indiana institution researchers pursuing direct institutional grants: - Build your internal profile at the IU Melvin and Bren Simon Comprehensive Cancer Center or Purdue Institute for Cancer Research. These institutions are the effective gateway — Walther's VP of Programs D. Craig Brater is embedded in IU's institutional planning. - Attend the annual ASCO Palliative and Supportive Care in Oncology Symposium (held each fall), where Walther leadership is consistently present and new award recipients are announced. - Request introductions through cancer center leadership and department chairs rather than contacting the foundation directly. Contact info (info@walther.org, (317) 708-6101) is appropriate only after an institutional introduction. - Develop a multi-year program vision. Walther does not fund one-off projects — all institutional commitments are structured as multi-year programs in the $5M–$15M range that build sustainable research infrastructure.

What to avoid: Do not frame proposals around community health, patient advocacy, or cancer prevention — Walther's explicit mission is discovery science and direct patient support, not population health or policy. Do not contact the foundation without an institutional intermediary for institutional grants.